0
Scientific Article   |    
Second-Generation Cementless Total Hip Arthroplasty Eight to Eleven-Year Results
Michael J. Archibeck, MD; Richard A. Berger, MD; Joshua J. Jacobs, MD; Laura R. Quigley, MS; Steven Gitelis, MD; Aaron G. Rosenberg, MD; Jorge O. Galante, MD
The Journal of Bone & Joint Surgery.  2001; 83:1666-1673 
5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Abstract

Background: Second-generation cementless femoral components were designed to provide more reliable ingrowth and to limit distal osteolysis by incorporating circumferential proximal ingrowth surfaces. We examined the eight to eleven-year results of total hip arthroplasty with a cementless, anatomically designed femoral component and a cementless hemispheric acetabular component.

Methods: Ninety-two consecutive primary total hip arthroplasties with implantation of a femoral component with a circumferential proximal porous coating (Anatomic Hip) and a cementless hemispheric porous-coated acetabular component (Harris-Galante II) were performed in eighty-five patients. These patients were prospectively followed clinically and radiographically. Six patients (seven hips) died and five patients (seven hips) were lost to follow-up, leaving seventy-four patients (seventy-eight hips) who had been followed for a mean of ten years (range, eight to eleven years). The mean age at the time of the arthroplasty was fifty-two years.

Results: The mean preoperative Harris hip score of 51 points improved to 94 points at the time of final follow-up; 86% of the hips had a good or excellent result. Thigh pain was reported as mild to severe after seven hip arthroplasties. No femoral component was revised for any reason, and none were loose radiographically at the time of the last follow-up. Two hips underwent acetabular revision (one because of dislocation and one because of loosening). Kaplan-Meier survivorship analysis was performed with revision or loosening of any component as the end point. The ten-year survival rate was 96.4% &plusmn 2.1% for the total hip prosthesis, 100% for the femoral component, and 96.4% &plusmn 2.1% for the acetabular component.

Radiolucencies adjacent to the nonporous portion of the femoral component were seen in sixty-eight (93%) of the -seventy-three hips with complete radiographic follow-up. Femoral osteolysis proximal to the lesser trochanter was noted in four hips (5%). No osteolysis was identified distal to the lesser trochanter. Periacetabular osteolysis was identified in twelve hips (16%). Five patients underwent exchange of the acetabular liner because of polyethylene wear.

Conclusions: This second-generation cementless, anatomically designed femoral component provided excellent clinical and radiographic results with a 100% survival rate at ten years. The circumferential porous coating of this implant improved ingrowth and prevented distal osteolysis at a mean of ten years after the arthroplasty.

Figures in this Article
    The initial results of cementless total hip arthroplasty with a variety of component designs have been variable, with failure rates ranging from 9% to 15% after two to seven years of follow-up1-9. More recent studies, on the use of second-generation cementless femoral components, have shown excellent results at both short and intermediate-term follow-up intervals10-13. However, there are still few reports on the results of the use of stems with a circumferential proximal porous coating that rely on metaphyseal osteointegration for fixation. The purpose of the present prospective study was to assess the clinical and radiographic outcomes, after an average of ten years of follow-up, in a consecutive series of patients treated with a second-generation, porous-coated total hip prosthesis.
     
    Anchor for JumpAnchor for Jump
    +Fig. 1-A:The Anatomic Hip femoral component (Zimmer, Warsaw, Indiana), an anatomically designed second-generation component with circumferential proximal porous coating.
     
    Anchor for JumpAnchor for Jump
    +Fig. 1-B:The Harris-Galante-II acetabular component (Zimmer, Warsaw, Indiana), a hemispherical porous-coated acetabular component with multiple screw-holes.
     
    Anchor for JumpAnchor for Jump
    +Fig. 2-A:At eleven years, large retroacetabular and trochanteric osteolytic lesions (arrows) were identified.
     
    Anchor for JumpAnchor for Jump
    +Fig. 2-B:Radiograph of the hip, made three months after exchange of the femoral head and the polyethylene liner and bone-grafting of the lesions.
    Between July 1988 and December 1990, eighty-five patients underwent a total of ninety-two total hip replacements in which a cementless, anatomically designed femoral component with a circumferential proximal porous coating (Anatomic Hip; Zimmer, Warsaw, Indiana) was coupled with a cementless hemispheric porous-coated acetabular component (Harris-Galante II; Zimmer). All operations were performed at a single institution by one of the four senior authors (J.J.J., S.G., A.G.R., or J.O.G.). The primary diagnosis was osteoarthritis in fifty-six hips (61%), avascular necrosis in twenty (22%), rheumatoid arthritis in eight (9%), posttraumatic arthritis in five (5%), psoriatic arthritis in two (2%), and ankylosing spondy-litis in one (1%). Of the eighty-five patients, six (seven hips) died before eight years (the minimum duration of follow-up) had elapsed and five (seven hips) were lost to follow-up. The remaining seventy-eight hips in seventy-four patients (forty-six men and twenty-eight women) were followed for a minimum of eight years. The average age at the time of the arthroplasty was fifty-two years (range, thirty-one to sixty-nine years). Four patients underwent staged bilateral hip reconstruction (from two to eleven months apart).
    The mean duration of follow-up was ten years (range, eight to eleven years). Although the results for the fourteen hips that were followed for less than eight years are reported and included in the survivorship analysis, they are not included in the final, eight to eleven-year results.
    The indications for cementless total hip arthroplasty included an age of less than seventy years and good bone quality (type A or B according to the system of Dorr et al.14). Hybrid total hip arthroplasty (with a cemented femoral component and an uncemented acetabular component) was performed in younger patients when an uncemented femoral component could not be used because of poor femoral bone stock, sub-optimal proximal femoral geometry, or an inability to comply with the weight-bearing limitations necessary for postop-erative rehabilitation after use of an uncemented femoral component. Furthermore, hybrid total hip arthroplasty was performed in younger patients with a lower-than-normal life expectancy because of cancer, severe inflammatory disease, or cardiopulmonary disease. During the time of this study, a total of 418 total hip replacements were implanted: 273 (65%) were hybrid, 144 (34%) were cementless, and one (0.2%) was cemented. Fifty-two of the 144 cementless arthroplasties were performed with implants of other designs (that is, not the -design evaluated in the present investigation) and thus were excluded from the present study. The remaining group of eighty-five patients in this study represent the younger and more active patients seen in our practice at that time.
    The Anatomic Hip is a curved collarless femoral component made of Ti-6-Al-4-V alloy with a commercially pure circumferential titanium fiber-metal porous coating diffusion bonded onto the proximal aspect of the implant (Fig. 1-A). The modular femoral head is a chromium-cobalt-alloy component mated to the femur by interference fit with a conical taper. A 28-mm head was used in all patients. The prosthetic design relies on maximum metaphyseal fill to provide initial implant stability. Flexible reamers were used to ream the medullary canal to the diameter of the desired stem, and this was followed by rasping of the metaphysis and canal. Torque testing was performed to confirm rotational stability by applying a 120 in-lb (13.5 Nm) retroversion force with a torque wrench to the final broach. If any motion of the broach was detected within the proximal part of the femur, the next larger broach was used until this motion was eliminated. In the event of an intraoperative, nondisplaced metaphyseal fracture, the broach or prosthesis was removed, cerclage wires were placed around the proximal part of the femur, and the final component was implanted.
    The acetabulum was reconstructed with use of a -porous-coated hemispherical component (Harris-Galante II) with a similarly prepared titanium fiber-metal ingrowth surface (Fig. 1-B). The acetabular component was inserted in a line-to-line fashion; the diameter of the implant matched the diameter of the last reamer used to prepare the acetabulum. Two, three, or four (mean, three) supplemental 6.5-mm-diameter screws were used in all patients. The polyethylene used at this time was machined and sterilized with gamma irradiation in air.
    The surgery was performed in a clean-air operating room with vertical laminar flow. The operating team wore body exhaust systems. The posterolateral approach was used in all patients. Prophylactic antibiotics, a first-generation cephalosporin unless contraindicated, were given preoperatively and continued for one to two days postoperatively. Suction drains were typically removed twenty-four to forty-eight hours postoperatively. All patients received a four-week course of warfarin for prophylaxis against venous thromboembolism. All patients walked with partial weight-bearing with two crutches for six weeks and then with full weight-bearing with crutches for an additional six weeks.

    Clinical and Radiographic Analysis

    Clinical and radiographic evaluation was performed preop-eratively and postoperatively at six weeks, three months, six months, one year, and annually thereafter. Clinical evaluation included physical examination and determination of the -Harris hip score15. A result was considered excellent when the Harris hip score was between 90 and 100 points, good when it was between 80 and 89 points, fair when it was between 70 and 79 points, and poor when it was <70 points. The patients were also questioned about thigh pain, and its severity was graded with use of the same 44-point scale as is used for the Harris hip pain score.
    Standard radiographs included an anteroposterior view of the pelvis and anteroposterior and lateral views of the proximal part of the femur. Two nonbiased observers who had not been involved in the implantation evaluated all radiographs. The six-week postoperative radiograph served as the baseline for identifying subsequent subsidence, remodeling of the femur, interfacial radiolucencies, osteolysis, and component loosening.
    On the anteroposterior16 and lateral17 radiographs, the femoral component was divided into seven zones. Radiolucencies at the bone-prosthesis interface were recorded as £1 mm, >1 mm but £2 mm, or >2 mm in width. Radiolucencies adjacent to the porous-coated portion of the stem were recorded separately. The extent and location of any osteolysis was recorded and was compared with that seen on previous radiographs. Subsidence was determined by measuring the distance between two lines drawn perpendicular to a longitudinal line through the center of the femoral canal18. The first perpendicular line was drawn at the level of the tip of the greater trochanter, and the second line was drawn at the junction of the lateral base of the Morse taper and the shoulder of the prosthesis. Any change of >2 mm in the distance between these two lines represented vertical subsidence of the femoral component18.
    Change in the position of the prosthesis into varus or valgus was determined by drawing a line through the center of the prosthesis and another through the center of the proximal part of the femur. A change of >2°, into varus or valgus, on comparable radiographs represented a change in stem orien-tation18. Remodeling changes in the proximal and distal parts of the femur including rounding of the calcar, cortical hypertrophy, and formation of an intramedullary bone pedestal were evaluated. Cortical hypertrophy was recorded for each Gruen zone16. The presence of a pedestal was recorded as partial or complete. Heterotopic ossification was graded according to the method of Brooker et al.19.
    The radiographs were also used to evaluate the status of the acetabular component with regard to stability, migration, radiolucency around screws, and periacetabular osteolysis. We classified the periacetabular osteolytic lesions as small (<1 cm in diameter), large (1 cm in diameter), or combined (two or more lesions in different size categories). We also categorized the lesions according to their location (peripheral, retroacetabular, or ischial).
    Wear of the acetabular component was measured with a digitized analysis, as described by Martell et al.18.
    Kaplan-Meier survivorship analysis20 was performed on the entire cohort of ninety-two hips.

    Clinical Results

    The average Harris hip score increased from 51 points (range, 24 to 76 points) preoperatively to 94 points (range, 48 to 100 points) at the time of final follow-up. Of the seventy-eight hips that were followed for more than eight years, fifty-six (72%) had an excellent result; eleven (14%), a good result; seven (9%), a fair result; and four (5%), a poor result. Of the four poor results, only one was related to the total hip arthroplasty; this patient reported moderate pain and a moderate limp from a 2-cm leg-length discrepancy. The other three poor results were related to contralateral hip osteoarthritis, spinal stenosis, or an unstable total knee prosthesis in a patient with rheumatoid arthritis.
    Patients were questioned about pain around the hip and thigh separately. At the time of final follow-up, fifty-nine hips (76%) were pain-free, eleven (14%) were slightly painful without compromising activity, six (8%) were mildly painful after activities, two (3%) were moderately painful and required concessions, and none were markedly painful or caused disabling pain. Seven hips (9%) were associated with mild-to-severe- thigh pain. Thigh pain was related to a larger stem size (p = 0.06, analysis of variance). Five hips (6%) were associated with mild thigh pain; one (1%), moderate thigh pain; and one (1%), disabling thigh pain. At the time of final follow-up, sixty hips (77%) were in patients with no limp; fourteen (18%), in those with a slight limp; three (4%), in those with a moderate limp; and one (1%), in a patient with a severe limp. Sixty-six hips (85%) were in patients who required no cane; six (8%), in those who required a cane only for long walks; four (5%), in those who required a cane full-time; and two (3%), in those who required a walker.
    In the entire cohort of ninety-two hips (eighty-five patients), four (4%) had an intraoperative complication: a nondisplaced metaphyseal fracture that occurred with implantation of the broach or the femoral component. In all four hips, two cerclage wires were placed and the implant was stable intraoperatively. All four femoral components subsequently had stable ingrowth. Postoperative complications included thromboembolic events in two patients. Bilateral lower-extremity thrombi developed two weeks postoperatively in one patient, and a symptomatic pulmonary embolus developed three weeks postoperatively in the other. There were four postoperative dislocations, all of which were initially treated with closed reduction and six weeks of bracing. Two of the patients had recurrent dislocations and required a reoperation: one of them had an acetabular revision at nine years, and the other had an exchange of the femoral head and the acetabular liner at seven years after the arthroplasty. No femoral component was revised.
    In the entire cohort of ninety-two hips, there were nine reoperations (10%) in eight patients. Seven acetabular reoperations (including two acetabular revisions) and two femoral reoperations were required. There were no femoral revisions. One patient required two reoperations: an exchange of the polyethylene liner because of excessive wear eight years after the arthroplasty and, one year later, revision to a constrained acetabular component because of recurrent dislocation. One patient fell, five years after the arthroplasty, and sustained a periprosthetic acetabular fracture with loosening of the acetabular component, which required revision six months after the fracture. One patient had recurrent (four) dislocations -requiring exchange of the liner and head at seven years after the arthroplasty. One patient had a pathologic fracture of the greater trochanter through an osteolytic lesion and required open reduction and internal fixation, bone-grafting of the lesion, and exchange of the liner and head at twelve years. Three additional patients required exchange of the liner and head with grafting of periacetabular and/or trochanteric areas of osteolysis at nine years (one patient) and ten years (two patients) after the arthroplasty. One patient required removal of a symptomatic cerclage wire from the proximal part of the femur.
    The fourteen hips in the eleven patients who had less than eight years of clinical follow-up were followed for a mean of fifty-four months (range, one to eighty months). The mean Harris hip score in this group increased from 50 points (range, 33 to 72 points) preoperatively to 88 points (range, 48 to 100 points) at the most recent follow-up evaluation. The result was excellent for ten hips, good for one, fair for one, and poor for two. At the time of final follow-up, ten hips were pain-free, two were slightly painful without compromising activity, none were mildly painful after activities, and two were moderately painful and required concessions. At the time of final follow-up, nine hips were in patients with no limp; two, in patients with a slight limp; and three, in patients with a moderate limp. Ten hips were in patients who did not require use of a cane, one was in a patient who used a cane only for long walks, and three were in patients who used a cane full-time. There was only one reoperation in this group, an acetabular revision, which was reported in the previous paragraph.

    Survivorship Analysis

    Kaplan-Meier survivorship analysis was performed with use of revision or loosening of any component as the end point. The ten-year rate of survival was 96.4% ± 2.1% for the total hip prosthesis, 100% for the femoral component, and 96.4% ± 2.1% for the acetabular component. With any reoperation as the end point, the ten-year survival rate was 91.9% ± 3.6%.

    Radiographic Results

    Of the seventy-eight hips in the seventy-two patients with a minimum of eight years of clinical follow-up, seventy-three had complete radiographic follow-up (mean, ten years; range, eight to eleven years). No femoral component had subsided, and one stem had a change of >2° into varus. This femoral component was undersized and had been implanted in slight varus. It had migrated into varus and was surrounded by a nearly complete radiolucency at thirty-six months. At the most recent follow-up examination, at 113 months, the femoral component had osseous growth into the proximal porous surfaces, as seen on anteroposterior and lateral radiographs, without subsidence or additional varus shift, and the Harris hip score was 100 points. In the overall series, forty-four (60%) of the stems were in neutral alignment, ten (14%) were in valgus alignment (mean, 1.5°), and sixteen (22%) were in varus alignment (mean, 3.1°) at the time of the last follow-up. The radiographs of three hips were inadequate for measurement of varus-valgus position.
    Qualitative changes in the proximal and distal parts of the femur were evaluated to assess the remodeling characteristics. Seventy-one hips (97%) had calcar rounding, which was partial in fifty-five hips (75%) and complete in sixteen (22%). Cortical hypertrophy was present in fifty-four hips (74%), with the most common locations being distal zones 3, 4, and 5 (affected in 19%, 23%, and 16% of the hips, respectively).
    An incomplete bone pedestal was present in fifty-nine hips (81%), and a complete pedestal was present in two (3%). Neither patient with a complete pedestal had other findings of loosening. Radiolucent lines were present in one or more zones in sixty-eight (93%) of the seventy-three hips at the last follow-up evaluation. All radiolucencies were £1 mm in width and were not progressive. On the anteroposterior radiographs, twenty-three hips (32%) had a radiolucency in zone 1; ten (14%), in zone 2; twenty-four (33%), in zone 3; forty-seven (64%), in zone 4; twenty-one (29%), in zone 5; twenty-three (32%), in zone 6; and thirty-one (42%), in zone 7. On the -lateral radiographs, twenty-two (30%) of the hips had a radiolucency in zone 1; seventeen (23%), in zone 2; twenty-nine (40%), in zone 3; forty-four (60%), in zone 4; thirty (41%), in zone 5; sixteen (22%), in zone 6; and twenty-seven (37%), in zone 7. These radiolucencies were adjacent to the nonporous portion of the stem, were nonprogressive, and were £1 mm in width. Two hips showed a 1-mm radiolucency adjacent to the porous ingrowth surface (zone 1) on the anteroposterior radiograph. One of these hips also had a lucency of <1 mm in zone 7 on the lateral radiograph. In both cases, there was evidence of bone growth into the other areas and no evidence of loosening. The last Harris hip scores of these two patients were 97 and 100 points.
    Osteolysis was adjacent to four femoral components (5%); three of the osteolytic lesions were in zone 1A, and one was in zone 7A. These four lesions were proximal to the lesser trochanter, and three of the four did not extend into the region of the porous surface. The fourth lesion was seen, on the anteroposterior radiograph, to incorporate the region of the porous surface, in zone 1, and it resulted in a pathologic fracture of the greater trochanter at 123 months. There was no osteolysis distal to the lesser trochanter in any hip.
    Acetabular radiolucency was present in zone A1 in twenty-one (29%) of the hips, in zone 2A in fourteen (19%), in zone B1 in six (8%), in zone B2 in twelve (16%), and in zone C in twenty-three (32%). All radiolucencies were <1 mm in width and were nonprogressive. No acetabular components were surrounded by a complete radiolucent line. Two acetabular components migrated >2 mm. One of the patients with acetabular migration was asymptomatic and did not require a reoperation. The other patient, in whom the migration was a result of periprosthetic fracture, had an acetabular revision. Radiolucencies were identified around screws in seven acetabular components. No screw broke.
    Osteolysis was identified adjacent to twelve (16%) of the acetabular components (Figs. 2-A and 2-B). The acetabular osteolytic lesions were large (1 cm in diameter) in six hips, small in five, and combined in one.
    The mean rate of wear of the acetabular component was 0.16 mm/yr (range, 0.00 to 0.47 mm/yr). An association between increased wear and younger age was identified (p < 0.001). There was no association between wear and diagnosis. Acetabular osteolysis was more common in patients with a higher wear rate and more total wear (p < 0.001, analysis of variance). Hips without acetabular osteolysis had an average wear rate of 0.015 mm/yr, whereas hips with acetabular osteolysis had an average wear rate of 0.27 mm/yr (p < 0.005, analysis of variance). There were four ischial lesions (all large), seven retroacetabular lesions (four small and three large), and three peripheral lesions (all small) in these twelve hips. Peripheral osteolysis was seen in younger patients, at an average age of thirty-six years at the time of the index arthroplasty, whereas retroacetabular and ischial osteolysis was seen in older patients, at an average age of fifty-four years at the time of the index arthroplasty (p = 0.003, analysis of variance).
    Of the seventy-three hips with more than eight years of radiographic follow-up, fifty-six (77%) were found to have heterotopic ossification. According to the method of Brooker et al.19, twenty hips (27%) had grade-I heterotopic ossification; thirty (41%), grade-II; six (8%), grade-III; and none, grade-IV. No patient was functionally limited by or required a reoperation secondary to heterotopic ossification.
    The fourteen hips in the eleven patients with less than eight years of follow-up were followed radiographically for a mean of fifty-four months (range, one to eighty-one months). Thirteen of the fourteen hips had radiolucency in at least one zone of the femoral component. All radiolucencies were <1 mm in width and were not progressive. There was no cortical hypertrophy in any hip at this short follow-up interval. No patients in this group had subsidence of >2 mm or a change in varus or valgus position of >2°. One patient had a femoral osteolytic lesion in zone 7A (proximal to the lesser trochanter) seen initially at sixty-seven months. Acetabular lucencies, all <1 mm, were seen in seven hips. There was no lucency around any screw. One patient had acetabular migration of >2 mm, which was initially recognized at sixty-nine months. The patient remained asymptomatic at the time of final follow-up, at eighty-nine months, and did not require revision. Two hips in one patient had osteolysis adjacent to the acetabular component. These were included in the group of acetabular components associated with osteolysis described above. One lesion was peripheral, and the other was small (<1 cm).
    The purpose of this prospective study was to evaluate the results at an average of ten years after a second-generation cementless total hip arthroplasty incorporating an anatomically designed femoral component with a circumferential proximal porous coating and a hemispheric acetabular component. At an average of ten years, 86% of the hips demonstrated a good or excellent clinical result. Furthermore, there was no aseptic femoral loosening and no femoral osteolysis distal to the lesser trochanter up to eleven years after the arthroplasty. Polyethylene wear and periacetabular osteolysis remain a concern in this relatively young and active patient population.
    As a result of the disappointing results associated with early proximally coated cementless femoral components such as the porous-coated anatomic implant (PCA; Howmedica, Rutherford, New Jersey)21,22 and the Harris-Galante-I implant (Zimmer, Warsaw, Indiana)18, the second-generation proximally coated femoral stems were developed. The Harris-Galante-I femoral component had a relatively small porous surface area that was noncircumferential, resulting in a susceptibility to distal osteolysis23,24. The clinical results in the present series, in which a second-generation proximally coated femoral component with a circumferential porous surface was used, compare favorably with those in previously published reports on -cemented femoral components25-29 and on other suc-cessful cementless designs10,11,30. While there are only limited intermediate-term data on these second-generation cementless proximally porous-coated femoral components, our findings of no loosening or distal osteolysis compare favorably with those available in the literature10,30,31.
    Our results compare favorably with the reported success rates of extensively porous-coated femoral components as well. Engh et al. reviewed the results of 174 consecutive arthroplasties with an extensively coated femoral component, followed for at least ten years, and found a 2% rate of femoral revision, a 2% rate of radiographic loosening, and a 97% rate of survival of the femoral component at twelve years11. They identified osteolysis in 39% of the hips. Kim et al. recently reported on fifty-two hips treated with an extensively porous-coated stem and identified a 2% femoral revision rate at a mean of eleven years32. They found a 55% rate of femoral osteolysis at this time, with the osteolysis distal to zones 1 and 7 in 17% (nine) of the hips.
    The results in our series of femoral components with a proximal circumferential coating also compare favorably with those in series of femoral components implanted with modern cementing techniques29,33,34.
    In our series, seven hips (9%) were associated with mild-to-severe thigh pain, which was mild in association with five hips and moderate and disabling in association with one each. In other series of proximally and fully coated femoral components, the prevalence of thigh pain has been variable, ranging from 1.5% to 27%10,11,22,35,36. In a recent study of the same prosthesis as was used in our study, Ragab et al. identified a 5% prevalence of thigh pain, not associated with stem size, at a mean of seven years30. In our study, thigh pain was associated with a larger stem size (analysis of variance, p = 0.06). In a study of the porous-coated anatomic prosthesis, Bourne et al. found a 27% prevalence of thigh pain at five years22. In our series, the prevalence of reported thigh pain did not decrease with increases in the duration of follow-up. Xenos et al., also in a study of the porous-coated anatomic prosthesis, found a peak prevalence of thigh pain of 23%, which decreased to 12% by ten years35. Vresilovic et al. found a prevalence of thigh pain of 12% in patients with a wedge-shaped cementless stem, and the prevalence correlated positively with the size of the stem36. Lastly, Engh et al. identified an 8% rate of thigh pain in their study of 174 extensively coated femoral stems followed for a minimum of ten years11.
    Fixation of cementless femoral components was classified by Engh et al. as stable with osseous ingrowth, stable with fibrous ingrowth, and unstable37. This classification system is dependent on a cylindrical implant and a radiograph made tangential to the porous surface. However, it is difficult to use the system for anatomically designed stems with limited ingrowth surfaces. Incomplete sclerotic and radiolucent lines adjacent to the prosthesis do not correlate well with implant stability. Most stems in our series had a radiolucent line in at least one zone; however, these lines were generally seen adjacent to the nonporous surface of the implant and were not associated with other changes indicative of stem loosening. We also identified an incomplete pedestal in fifty-nine hips (81%) and a complete pedestal in two (3%). In none of these hips was there other evidence of aseptic loosening, such as subsidence or complete radiolucency, and most stems had clear evidence of osteointegration as seen by trabecularization into the pads. Ragab et al., in their review of the same stem as was used in our series, found a partial pedestal in twenty-eight hips (29%), all of which had a radiographically stable implant30. In the case of proximally porous-coated femoral components, therefore, radiographic subsidence or a complete radiolucent line is an indicator of loosening, whereas partial radiolucencies that are not adjacent to the ingrowth surface and pedestal formation are not. Lastly, trabecularization into ingrowth pads is an indication of osteointegration.
    Particulate debris from polyethylene wear and resultant osteolysis remain the primary factors limiting the longevity of hip prostheses38. While a tight seal at the bone-implant interface and stable fixation without motion potentially inhibit or slow migration of the debris to the distal femoral zones, periacetabular osteolysis has become relatively common at intermediate follow-up intervals4,10,11,22,30,35,39,40. The femoral osteolysis seen in our series (in 5% of the hips) was localized to Gruen zones 1 and 7, proximal to the lesser trochanter. No hip had osteolysis distal to the lesser trochanter. However, we identified an 8% rate of small periacetabular osteolytic lesions and an 8% rate of large lesions. Despite this high rate of osteolysis, acetabular ingrowth and fixation remained excellent, with only one revision for aseptic loosening (following a periprosthetic acetabular fracture).
    We showed that the presence of these osteolytic lesions is directly related to polyethylene wear, with acetabular osteolysis more likely to develop in patients with a higher wear rate. Furthermore, the location of these osteolytic lesions—that is, peripheral compared with retroacetabular—was related to age, with peripheral osteolysis developing in younger patients. Perhaps this is ultimately related to bone quality, as patients with poor bone quality are susceptible to retroacetabular osteolysis. Given these findings, screening radiographs at annual intervals and early intervention are warranted to prevent the difficult situation that results from advanced osteolysis and loosening. In addition, as plain radiographs often underestimate the extent of osteolysis, especially adjacent to the hemispherical acetabular component, we have found computed tomography to be of assistance in characterizing lesions found on plain radiographs.
    The outcome of cementless total hip arthroplasty depends on many factors, including component design, patient selection, and surgical technique. Our results at a mean of ten years suggest that the use of a second-generation, circumferentially porous-coated femoral stem provides reproducible ingrowth and excellent clinical results. However, polyethylene wear and its sequelae remain matters of concern in this relatively young and active group of patients.
    Callaghan JJ, Dysart SH,Savory CG. The uncemented porous-coated anatomic total hip prosthesis. Two-year results of a prospective consecutive series. J Bone Joint Surg Am,1988;70: 337-46. 70337  1988  [PubMed]
     
    Callaghan JJ. The clinical results and basic science of total hip arthroplasty with porous-coated prostheses. J Bone Joint Surg Am,1993;75: 299-310. 75299  1993  [PubMed]
     
    Engh CA, Bobyn JD,Glassman AH. Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br,1987;69: 45-55. 6945  1987  [PubMed]
     
    Kim YH,Kim VE. Early migration of uncemented porous coated anatomic femoral component related to aseptic loosening. Clin Orthop,1993;295: 146-55. 295146  1993  [PubMed]
     
    Lautiainen IA, Joukainen J,Makela EA. Clinical and roentgenographic results of cementless total hip arthroplasty. J Arthroplasty,1994;9: 653-60. 9653  1994  [PubMed][CrossRef]
     
    Learmonth ID, Grobler GP, Dall DM,Jandera V. Loss of bone stock with cementless hip arthroplasty. J Arthroplasty,1995;10: 257-63. 10257  1995  [PubMed][CrossRef]
     
    Morscher EW. Cementless total hip arthroplasty. Clin Orthop,1983;181: 76-91. 18176  1983  [PubMed]
     
    Owen TD, Moran CG, Smith SR,Pinder IM. Results of uncemented porous-coated anatomic total hip replacement. J Bone Joint Surg Br,1994;76-: 258-62. 76-258  1994  [PubMed]
     
    Smith E,Harris WH. Increasing prevalence of femoral lysis in cementless total hip arthroplasty. J Arthroplasty,1995;10: 407-12. 10407  1995  [PubMed][CrossRef]
     
    Sakalkale DP, Eng K, Hozack WJ,Rothman RH. Minimum 10-year results of a tapered cementless hip replacement. Clin Orthop,1999;362: 138-44.. 362138  1999  [PubMed]
     
    Engh CA Jr, Culpepper WJ 2nd,Engh CA. Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty. J Bone Joint Surg Am,1997;79: 177-84. 79177  1997  [PubMed][CrossRef]
     
    Engh CA, Glassman AH,Suthers KE. The case for porous-coated hip implants. The femoral side. Clin Orthop,1990;261: 63-81. 26163  1990  [PubMed]
     
    Pellegrini VD Jr, Hughes SS,Evarts CM. A collarless cobalt-chrome femoral component in uncemented total hip arthroplasty. Five- to eight--year follow-up. J Bone Joint Surg Br,1992;74: 814-21. 74814  1992  [PubMed]
     
    Dorr L, Faugere M, Mackel A, Gruen TA, Bognar B,Malluche HH. Structural and cellular assessment of bone quality of proximal femur. Bone,1993;14: 231-42.. 14231  1993  [PubMed][CrossRef]
     
    Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am,1969;51: 737-55. 51737  1969  [PubMed]
     
    Gruen TA, McNeice GM,Amstutz HC. "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop,1979;141: 17-27. 14117  1979  [PubMed]
     
    Johnston RC, Fitzgerald RH, Harris WH, Poss R, Muller ME,Sledge CB. Clinical and radiographic evaluation of total hip replacement. A standard system of terminology for reporting results. J Bone Joint Surg Am,1990;72: 161-8. 72161  1990  [PubMed]
     
    Martell JM, Pierson RH 3rd, Jacobs JJ, Rosenberg AG, Maley M,Galante JO. Primary total hip reconstruction with a titanium fiber-coated prosthesis inserted without cement. J Bone Joint Surg Am,1993;75: 554-71. 75554  1993  [PubMed]
     
    Brooker AF, Bowerman JW, Robinson RA,Riley LH Jr. Ectopic ossification -following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am,1973;55: 1629-32. 551629  1973  [PubMed]
     
    Kaplan E,Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assn,1958;53: 457-81. 53457  1958  [CrossRef]
     
    Kim YH,Kim VE. Uncemented porous-coated anatomic total hip replacement. Results at six years in a consecutive series. J Bone Joint Surg Br,1993;75: 6-13. 756  1993  [PubMed]
     
    Bourne RB, Rorabeck CH, Ghazal ME,Lee MH. Pain in the thigh following total hip replacement with a porous-coated anatomic prosthesis for osteoarthrosis. A five-year follow-up study. J Bone Joint Surg Am,1994;76: 1464-70. 761464  1994  [PubMed]
     
    Urban RM, Jacobs JJ, Sumner DR, Peters CL, Voss FR,Galante JO. The bone-implant interface of femoral stems with non-circumferential porous coating. J Bone Joint Surg Am,1996;78: 1068-81. 781068  1996  [PubMed]
     
    Bobyn JD, Jacobs JJ, Tanzer M, Urban RM, Aribindi R, Sumner DR, Turner TM,Brooks CE. The susceptibility of smooth implant surfaces to periimplant fibrosis and migration of polyethylene wear debris. Clin Orthop,1995;311: 21-39. 31121  1995  [PubMed]
     
    Hozack WJ, Rothman RH, Booth RE Jr,Balderston RA. Cemented versus cementless total hip arthroplasty. A comparative study of equivalent patient populations. Clin Orthop,1993;289: 161-5.. 289161  1993  [PubMed]
     
    Maloney WJ, Sychterz C, Bragdon C, McGovern T, Jasty M, Engh CA,Harris WH. The Otto Aufranc Award. Skeletal response to well fixed femoral components inserted with and without cement. Clin Orthop,1996;333: 15-26. 33315  1996  [PubMed]
     
    Mulliken BD, Nayak N, Bourne RB, Rorabeck CH,Bullas R. Early radiographic results comparing cemented and cementless total hip arthroplasty. J Arthroplasty,1996;11: 24-33. 1124  1996  [PubMed][CrossRef]
     
    Russotti GM, Coventry MB,Stauffer RN. Cemented total hip arthroplasty with contemporary techniques. A five-year minimum follow-up study. Clin Orthop,1988;235: 141-7.. 235141  1988  [PubMed]
     
    Berger RA, Kull LR, Rosenberg AG,Galante JO. Hybrid total hip arthroplasty: 7- to 10-year results. Clin Orthop,1996;333: 134-46.. 333134  1996  [PubMed]
     
    Ragab AA, Kraay MJ,Goldberg VM. Clinical and radiographic outcomes of total hip arthroplasty with insertion of an anatomically designed femoral component without cement for the treatment of primary osteoarthritis. A study with a minimum of six years of follow-up. J Bone Joint Surg Am,1999;81: 210-8. 81210  1999  [PubMed]
     
    Mallory TH, Head WC, Lombardi AV Jr, Emerson RH Jr, Eberle RW,Mitchell MB. Clinical and radiographic outcome of a cementless, titanium, plasma spray-coated total hip arthroplasty femoral component. Justification for continuance of use. J Arthroplasty,1996;11: 653-60. 11653  1996  [PubMed][CrossRef]
     
    Kim YH, Kim JS,Cho SH. Primary total hip arthroplasty with the AML total hip prosthesis. Clin Orthop,1999;360: 147-58. 360147  1999  [PubMed][CrossRef]
     
    Mulroy WF, Estok DM,Harris WH. Total hip arthroplasty with use of so-called second-generation cementing techniques. A fifteen-year-average follow-up study. J Bone Joint Surg Am,1995;77: 1845-52. 771845  1995  [PubMed]
     
    Smith SE, Estok DM 2nd,Harris WH. 20-year experience with cemented primary and conversion total hip arthroplasty using so-called second--generation cementing techniques in patients aged 50 years or younger. J Arthroplasty,2000;15: 263-73. 15263  2000  [PubMed][CrossRef]
     
    Xenos JS, Callaghan JJ, Heekin RD, Hopkinson WJ, Savory CG,Moore MS. The porous-coated anatomic total hip prosthesis, inserted without cement. A prospective study with a minimum of ten years of follow-up. J Bone Joint Surg Am,1999;81: 74-82. 8174  1999  [PubMed]
     
    Vresilovic EJ, Hozack WJ,Rothman RH. Incidence of thigh pain after uncemented total hip arthroplasty as a function of femoral stem size. J Arthroplasty,1996;11: 304-11. 11304  1996  [PubMed][CrossRef]
     
    Engh CA, Massin P,Suthers KE. Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop,1990;257: 107-28. 257107  1990  [PubMed]
     
    Harris WH. The problem is osteolysis. Clin Orthop,1995;311: 46-53. 31146  1995  [PubMed]
     
    Berger RA, Jacobs JJ, Quigley LR, Rosenberg AG,Galante JO. Primary cementless acetabular reconstruction in patients younger than 50 years old. 7- to 11-year results. Clin Orthop,1997;344: 216-26. 344216  1997  [PubMed]
     
    D’Antonio JA, Capello WN,Jaffe WL. Hydroxylapatite-coated hip implants. Multicenter three-year clinical and roentgenographic results. Clin Orthop,1992;285: 102-15. 285102  1992  [PubMed]
     

    Submit a comment

    Anchor for JumpAnchor for Jump
    +Fig. 1-A:The Anatomic Hip femoral component (Zimmer, Warsaw, Indiana), an anatomically designed second-generation component with circumferential proximal porous coating.
    Anchor for JumpAnchor for Jump
    +Fig. 1-B:The Harris-Galante-II acetabular component (Zimmer, Warsaw, Indiana), a hemispherical porous-coated acetabular component with multiple screw-holes.
    Anchor for JumpAnchor for Jump
    +Fig. 2-A:At eleven years, large retroacetabular and trochanteric osteolytic lesions (arrows) were identified.
    Anchor for JumpAnchor for Jump
    +Fig. 2-B:Radiograph of the hip, made three months after exchange of the femoral head and the polyethylene liner and bone-grafting of the lesions.
    Callaghan JJ, Dysart SH,Savory CG. The uncemented porous-coated anatomic total hip prosthesis. Two-year results of a prospective consecutive series. J Bone Joint Surg Am,1988;70: 337-46. 70337  1988  [PubMed]
     
    Callaghan JJ. The clinical results and basic science of total hip arthroplasty with porous-coated prostheses. J Bone Joint Surg Am,1993;75: 299-310. 75299  1993  [PubMed]
     
    Engh CA, Bobyn JD,Glassman AH. Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br,1987;69: 45-55. 6945  1987  [PubMed]
     
    Kim YH,Kim VE. Early migration of uncemented porous coated anatomic femoral component related to aseptic loosening. Clin Orthop,1993;295: 146-55. 295146  1993  [PubMed]
     
    Lautiainen IA, Joukainen J,Makela EA. Clinical and roentgenographic results of cementless total hip arthroplasty. J Arthroplasty,1994;9: 653-60. 9653  1994  [PubMed][CrossRef]
     
    Learmonth ID, Grobler GP, Dall DM,Jandera V. Loss of bone stock with cementless hip arthroplasty. J Arthroplasty,1995;10: 257-63. 10257  1995  [PubMed][CrossRef]
     
    Morscher EW. Cementless total hip arthroplasty. Clin Orthop,1983;181: 76-91. 18176  1983  [PubMed]
     
    Owen TD, Moran CG, Smith SR,Pinder IM. Results of uncemented porous-coated anatomic total hip replacement. J Bone Joint Surg Br,1994;76-: 258-62. 76-258  1994  [PubMed]
     
    Smith E,Harris WH. Increasing prevalence of femoral lysis in cementless total hip arthroplasty. J Arthroplasty,1995;10: 407-12. 10407  1995  [PubMed][CrossRef]
     
    Sakalkale DP, Eng K, Hozack WJ,Rothman RH. Minimum 10-year results of a tapered cementless hip replacement. Clin Orthop,1999;362: 138-44.. 362138  1999  [PubMed]
     
    Engh CA Jr, Culpepper WJ 2nd,Engh CA. Long-term results of use of the anatomic medullary locking prosthesis in total hip arthroplasty. J Bone Joint Surg Am,1997;79: 177-84. 79177  1997  [PubMed][CrossRef]
     
    Engh CA, Glassman AH,Suthers KE. The case for porous-coated hip implants. The femoral side. Clin Orthop,1990;261: 63-81. 26163  1990  [PubMed]
     
    Pellegrini VD Jr, Hughes SS,Evarts CM. A collarless cobalt-chrome femoral component in uncemented total hip arthroplasty. Five- to eight--year follow-up. J Bone Joint Surg Br,1992;74: 814-21. 74814  1992  [PubMed]
     
    Dorr L, Faugere M, Mackel A, Gruen TA, Bognar B,Malluche HH. Structural and cellular assessment of bone quality of proximal femur. Bone,1993;14: 231-42.. 14231  1993  [PubMed][CrossRef]
     
    Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment by mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am,1969;51: 737-55. 51737  1969  [PubMed]
     
    Gruen TA, McNeice GM,Amstutz HC. "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening. Clin Orthop,1979;141: 17-27. 14117  1979  [PubMed]
     
    Johnston RC, Fitzgerald RH, Harris WH, Poss R, Muller ME,Sledge CB. Clinical and radiographic evaluation of total hip replacement. A standard system of terminology for reporting results. J Bone Joint Surg Am,1990;72: 161-8. 72161  1990  [PubMed]
     
    Martell JM, Pierson RH 3rd, Jacobs JJ, Rosenberg AG, Maley M,Galante JO. Primary total hip reconstruction with a titanium fiber-coated prosthesis inserted without cement. J Bone Joint Surg Am,1993;75: 554-71. 75554  1993  [PubMed]
     
    Brooker AF, Bowerman JW, Robinson RA,Riley LH Jr. Ectopic ossification -following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am,1973;55: 1629-32. 551629  1973  [PubMed]
     
    Kaplan E,Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assn,1958;53: 457-81. 53457  1958  [CrossRef]
     
    Kim YH,Kim VE. Uncemented porous-coated anatomic total hip replacement. Results at six years in a consecutive series. J Bone Joint Surg Br,1993;75: 6-13. 756  1993  [PubMed]
     
    Bourne RB, Rorabeck CH, Ghazal ME,Lee MH. Pain in the thigh following total hip replacement with a porous-coated anatomic prosthesis for osteoarthrosis. A five-year follow-up study. J Bone Joint Surg Am,1994;76: 1464-70. 761464  1994  [PubMed]
     
    Urban RM, Jacobs JJ, Sumner DR, Peters CL, Voss FR,Galante JO. The bone-implant interface of femoral stems with non-circumferential porous coating. J Bone Joint Surg Am,1996;78: 1068-81. 781068  1996  [PubMed]
     
    Bobyn JD, Jacobs JJ, Tanzer M, Urban RM, Aribindi R, Sumner DR, Turner TM,Brooks CE. The susceptibility of smooth implant surfaces to periimplant fibrosis and migration of polyethylene wear debris. Clin Orthop,1995;311: 21-39. 31121  1995  [PubMed]
     
    Hozack WJ, Rothman RH, Booth RE Jr,Balderston RA. Cemented versus cementless total hip arthroplasty. A comparative study of equivalent patient populations. Clin Orthop,1993;289: 161-5.. 289161  1993  [PubMed]
     
    Maloney WJ, Sychterz C, Bragdon C, McGovern T, Jasty M, Engh CA,Harris WH. The Otto Aufranc Award. Skeletal response to well fixed femoral components inserted with and without cement. Clin Orthop,1996;333: 15-26. 33315  1996  [PubMed]
     
    Mulliken BD, Nayak N, Bourne RB, Rorabeck CH,Bullas R. Early radiographic results comparing cemented and cementless total hip arthroplasty. J Arthroplasty,1996;11: 24-33. 1124  1996  [PubMed][CrossRef]
     
    Russotti GM, Coventry MB,Stauffer RN. Cemented total hip arthroplasty with contemporary techniques. A five-year minimum follow-up study. Clin Orthop,1988;235: 141-7.. 235141  1988  [PubMed]
     
    Berger RA, Kull LR, Rosenberg AG,Galante JO. Hybrid total hip arthroplasty: 7- to 10-year results. Clin Orthop,1996;333: 134-46.. 333134  1996  [PubMed]
     
    Ragab AA, Kraay MJ,Goldberg VM. Clinical and radiographic outcomes of total hip arthroplasty with insertion of an anatomically designed femoral component without cement for the treatment of primary osteoarthritis. A study with a minimum of six years of follow-up. J Bone Joint Surg Am,1999;81: 210-8. 81210  1999  [PubMed]
     
    Mallory TH, Head WC, Lombardi AV Jr, Emerson RH Jr, Eberle RW,Mitchell MB. Clinical and radiographic outcome of a cementless, titanium, plasma spray-coated total hip arthroplasty femoral component. Justification for continuance of use. J Arthroplasty,1996;11: 653-60. 11653  1996  [PubMed][CrossRef]
     
    Kim YH, Kim JS,Cho SH. Primary total hip arthroplasty with the AML total hip prosthesis. Clin Orthop,1999;360: 147-58. 360147  1999  [PubMed][CrossRef]
     
    Mulroy WF, Estok DM,Harris WH. Total hip arthroplasty with use of so-called second-generation cementing techniques. A fifteen-year-average follow-up study. J Bone Joint Surg Am,1995;77: 1845-52. 771845  1995  [PubMed]
     
    Smith SE, Estok DM 2nd,Harris WH. 20-year experience with cemented primary and conversion total hip arthroplasty using so-called second--generation cementing techniques in patients aged 50 years or younger. J Arthroplasty,2000;15: 263-73. 15263  2000  [PubMed][CrossRef]
     
    Xenos JS, Callaghan JJ, Heekin RD, Hopkinson WJ, Savory CG,Moore MS. The porous-coated anatomic total hip prosthesis, inserted without cement. A prospective study with a minimum of ten years of follow-up. J Bone Joint Surg Am,1999;81: 74-82. 8174  1999  [PubMed]
     
    Vresilovic EJ, Hozack WJ,Rothman RH. Incidence of thigh pain after uncemented total hip arthroplasty as a function of femoral stem size. J Arthroplasty,1996;11: 304-11. 11304  1996  [PubMed][CrossRef]
     
    Engh CA, Massin P,Suthers KE. Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop,1990;257: 107-28. 257107  1990  [PubMed]
     
    Harris WH. The problem is osteolysis. Clin Orthop,1995;311: 46-53. 31146  1995  [PubMed]
     
    Berger RA, Jacobs JJ, Quigley LR, Rosenberg AG,Galante JO. Primary cementless acetabular reconstruction in patients younger than 50 years old. 7- to 11-year results. Clin Orthop,1997;344: 216-26. 344216  1997  [PubMed]
     
    D’Antonio JA, Capello WN,Jaffe WL. Hydroxylapatite-coated hip implants. Multicenter three-year clinical and roentgenographic results. Clin Orthop,1992;285: 102-15. 285102  1992  [PubMed]
     
    Accreditation Statement
    These activities have been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of Orthopaedic Surgeons and The Journal of Bone and Joint Surgery, Inc. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
    CME Activities Associated with This Article
    Submit a Comment
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discretion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe




    Related Articles
    Related Cases
    Related Content
    Topic Collections
    Hip
    Related Audio and Videos
    PubMed Articles
    Guidelines
    The treatment of glenohumeral joint osteoarthritis. -American Academy of Orthopaedic Surgeons (AAOS) | 9/11/2009
    Results provided by:
    PubMed
    Clinical Trials
    Readers of This Also Read...
    jbjs jobs
    05/18/2012
    TX - University of North Texas Health Science Center
    01/04/2012
    LA - LSU Health Shreveport
    01/04/2012
    PA - Penn State Milton S. Hershey Medical Center - Dept. of Orthopaedics & Rehabilitation
    05/18/2012
    NY - SUNY-Downstate Medical Center